The 20 Best Schwannoma Doctors Near Me in Ann Arbor, MI

Dr. Emily Stucken is an associate professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. She specializes in diseases of the ear and skull base. Dr. Stucken completed a residency in Otolaryngology-Head and Neck Surgery at New York Presbyterian Hospital, the University Hospital of Columbia and Cornell. During this time, she also performed skull base operations at Memorial Sloan Kettering Cancer Center and trained in pediatric otolaryngology at the Children’s Hospital of New York. Dr. Stucken completed advanced fellowship training in otology and neurotology at the Michigan Ear Institute. Dr. Stucken has received awards for excellence in clinical care, teaching, and research. She has published numerous scholarly articles and book chapters in peer-reviewed journals and otolaryngology texts. She is an active member of the American Academy of Otolaryngology–Head and Neck Surgery and the American Neurotology Society and serves on national committees for these organizations. Dr. Stucken is also involved in humanitarian outreach work and has traveled to Cambodia to perform ear surgery on underserved patients. She is proficient in Spanish and French.Dr. Stucken is the director of the Cochlear Implant Center at the University of Michigan. In addition to her clinical practice, Dr. Stucken is invested in the advancement of knowledge and is an NIH-funded researcher in hearing sciences. She is a clinical faculty member at the Kresge Hearing Research Institute and has led international research collaboration. Dr. Stucken also runs the Temporal Bone Dissection Lab at the University of Michigan and directs the Temporal Bone Dissection Course.Dr. Stucken’s approach to otolaryngology and otology-neurotology combines a strong background of clinical and academic expertise with a dedicated personal approach to patient care. Through this personal approach, she works to help patients understand their disease process and treatment options. The ear represents one of the most complex and intricate organs in the human body; just as diseases of the ear and skull base can be debilitating to a person’s interactions with the everyday world, the treatment for these diseases can restore a patient’s quality of life. Dr. Stucken works diligently toward providing specialized care to every patient on an individual basis to achieve the best possible outcomes. Dr. Stucken is rated as a Distinguished provider by MediFind in the treatment of Schwannoma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Acoustic Neuroma, Schwannoma, Glomus Tympanum Tumor, Glomus Jugulare Tumor, and Myringotomy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

Dr. B. Gregory Thompson was born in Kansas City, Missouri, the oldest son in a family of eleven children. Dr. Thompson attended Harvard College, where he played football and studied English and biology. He graduated from the University of Kansas School of Medicine and subsequently entered neurosurgery residency training at the University of Pittsburgh, where he did elective rotations in neurology at Queen Square in London, England, and as a Medical Staff Research Fellow at the National Institutes of Health in Bethesda, Maryland.Following his residency in Pittsburgh, Dr. Thompson did a neurovascular and skull base surgery fellowship at the Barrow Neurological Institute and began his academic career at the University of Utah. He was then recruited to the University of Michigan.After 10 years in practice, Dr. Thompson recognized that the rapid technological and clinical development of interventional neuroradiology was a force rapidly changing cerebrovascular surgery and training, and so he returned to training as a fellow in Endovascular Neurological Surgery (ENS) at Thomas Jefferson University in Philadelphia.Upon returning full time to the University of Michigan in 2005, he became Vice Chairman of the Neurosurgery Department and established a curriculum for neurosurgery resident education in ENS. He also subsequently established a “dual training” cerebrovascular fellowship which encompasses both endovascular and advanced microsurgical techniques.Working also with a cranial base team of six otologists at Michigan, Dr Thompson has operated more than 1,000 patients with vestibular schwannomas, and their Michigan team has reported significantly improved hearing preservation results with the Middle Fossa Approach.Dr. Thompson received the University of Michigan’s Medical Student Award for Teaching Excellence in Neuroscience, the University’s Outstanding Clinician Award, and was an inaugural member of the University’s League of Clinical Excellence. He was honored with the Cerebrovascular Section’s Alfred J. Luessenhop Award in Cerebrovascular Surgery in 2011, and was appointed as a Director of the American Board of Neurological Surgery in 2012. He currently serves as the Chair of the ABNS. Dr. Thompson and his wife Ramona have 7 children and reside in Ann Arbor.50813181. Dr. Thompson is rated as a Distinguished provider by MediFind in the treatment of Schwannoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, Thrombectomy, and Gastrostomy.

Hussam El is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. El is rated as a Distinguished provider by MediFind in the treatment of Schwannoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Infant Hearing Loss, and DFNB1. Dr. El is board certified in Otolaryngology-Head & Neck Surgery.

Meredith Adams is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Adams is rated as a Distinguished provider by MediFind in the treatment of Schwannoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Schwannoma, Acoustic Neuroma, Labyrinthitis, Vertigo, and Mastoidectomy. Dr. Adams is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

Steven Telian is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Telian is rated as a Distinguished provider by MediFind in the treatment of Schwannoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Schwannoma, Vertigo, and Meniere Disease.

Christopher Welch is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Welch is rated as an Advanced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Cholesteatoma, Schwannoma, and Infant Hearing Loss. Dr. Welch is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

Dr. Renee Banakis Hartl is an Assistant Professor of Otology and Neurotology in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. She specializes in diseases of the ear and hearing. Prior to attending medical school, Dr. Banakis Hartl completed a clinical doctorate degree in Audiology at Northwestern University. She subsequently completed residency training in Otolaryngology-Head and Neck Surgery at the University of Colorado, and she then went on to complete advanced fellowship training in Otology and Neurotology at the University of Michigan Ear. Dr. Banakis Hartl published numerous scholarly articles in peer-reviewed journals and written several book chapters in otolaryngology texts. She is an active member of the American Academy of Otolaryngology–Head and Neck Surgery and the American Neurotology Society. She is proficient in Spanish and American Sign Language.In addition to her clinical practice, Dr. Banakis Hartl has a strong interest in the advancement of scientific knowledge and is a funded researcher in hearing sciences. She is a clinical faculty member at the Kresge Hearing Research Institute and runs a human psychophysics lab where she leads research investigating binaural hearing, hearing impairment, and single-sided deafness using a specialized anechoic research chamber. Dr. Hartl is rated as an Advanced provider by MediFind in the treatment of Schwannoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Hearing Loss, Cholesteatoma, Acoustic Neuroma, and Schwannoma. Dr. Hartl is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as an Advanced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Dr. Saadeh was born and raised in Ann Arbor, and attended the University of Michigan for undergraduate studies. After completing medical school at Michigan State University, he returned to the University of Michigan for residency and fellowship training, and was trained by the late Dr. Lynda Yang as her fellow in brachial plexus peripheral nerve surgery. He also spent several months at Leiden University in the Netherlands for training in pediatric brachial plexus surgery with Dr. Martijn Malessy. Dr Saadeh also completed a fellowship in minimally invasive and complex spine with Dr. Paul Park.Outside of taking care of patients, Dr. Saadeh enjoys spending time with his wife and 2 daughters, staying active with sports and community work, and keeping busy with DIY projects. Dr. Saadeh is rated as an Advanced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Brachial Plexopathy, Epidural Hematoma, Spinal Stenosis, Laminectomy, and Spinal Fusion. Dr. Saadeh is board certified in Neurological Surgery.

Michael Karsy, MD, PhD, MSc, FAANS is a Clinical Assistant Professor of Neurosurgery at the University of Michigan. He completed his undergraduate degree with honors in Neuroscience at the University of California Los Angeles and a combined MD/PhD program at New York Medical College. He then completed residency in neurosurgery at the University of Utah under Dr. William Couldwell in 2020 with enfolded fellowship in Complex Spine Surgery with Dr. Andrew Dailey and Dr. Erica Bisson as well as a Masters of Bioengineering in Medical Device Development. And he completed a Skull Base fellowship at Thomas Jefferson University Hospital under Dr. James Evans in 2021.He practices at both the University of Michigan Health – Sparrow and University of Michigan Health – Ann Arbor. His primary focus is on neuro-oncology and skull base pathologies with specialization in endoscopic and minimally invasive approaches. He works as part of a large multi-disciplinary team managing neuro-oncology issues (e.g., pituitary adenomas, meningiomas, gliomas, vestibular schwannomas, metastatic disease). He also has an interest in spine management (e.g., minimally invasive spine surgery, cervical myelopathy, spine tumors, trauma, deformity). Dr. Karsy also currently serves as the Director of Clinical Operations and Quality at University of Michigan Health – Sparrow and previously served as faculty at the University of Utah and Drexel University College of Medicine.His research interests are in molecular characterization and targeted therapy of skull base pathologies, multi-institutional collaboration to advance skull base research, improving healthcare outcomes, and reducing surgical complications through improved integration of techniques and technology in neurosurgery. He has >200 publications, a dozen book chapters, and a surgical textbook. He has participated as a co-investigator and principal investigator on multiple clinical trials in neurosurgical trauma, critical care, and neuro-oncology. Dr. Karsy enjoys working with medical students, residents, and fellows both locally and nationally in a variety of research endeavors. He is currently active in the North American Skull Base Society among areas of organized neurosurgery.Dr. Karsy is Board Certified by the American Board of Neurological Surgery. He also speaks Persian and Spanish. In his spare time, he enjoys reading, movies, mountain biking, hiking, and spending time with his wife and two children. Dr. Karsy is rated as an Advanced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Hypothalamic Tumor, Pituitary Tumor, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Thrombectomy.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Schwannoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Nick Szerlip is originally from New York, just north of Manhattan, but lived many places around the country while growing up. He attended Columbia University for his undergraduate studies, where he obtained a bachelor’s degree in psychology. He then attended Tulane University School of Medicine in New Orleans, where he obtained his medical degree. After graduating medical school, Dr. Szerlip completed his residency training at the University of Maryland in Baltimore.Dr. Szerlip obtained additional fellowship training during a fellowship at the National Institutes of Health (NIH), where he examined the origins of cancer cells and effective drug delivery to treat cancer, followed by a fellowship in neurosurgical oncology at Memorial Sloan Kettering Cancer Center in New York. The direction of his neurosurgical career has largely been shaped by the loss of his mother to metastatic cancer in the early part of his neurosurgery residency. Her legacy drives him to be a better physician, to search for a solution to spine cancer, and to train future neurosurgeons to approach their patients with the skill, compassion, and respect they deserve during a very difficult time.Clinically, Dr. Szerlip treats disorders of the spine including arthritis, malalignment and specializes in surgical and radiation treatment of spine tumors. His goal at the University of Michigan is to continue to build a clinical and translational spine oncology program that will enable the clinic and the laboratory to work together as partners to rapidly advance care for spine cancer. This model will foster synergy among physicians and researchers, affording our patients access to the latest clinical trials and outstanding, compassionate care; it will also accelerate new therapies for future patients. Dr. Szerlip is rated as an Advanced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Hemangioblastoma, Fractured Spine, Laminectomy, and Microdiscectomy. Dr. Szerlip is board certified in Neurological Surgery.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

Katherine Heidenreich is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Heidenreich is rated as an Experienced provider by MediFind in the treatment of Schwannoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Vertigo, Nonsyndromic Hearing Loss, Meniere Disease, and Deafness Hypogonadism Syndrome. Dr. Heidenreich is board certified in Otolaryngology-Head & Neck Surgery.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

Dr. Venkatakrishna Rajajee completed his medical training at the Madras Medical College in India. He completed his residency in Neurology at the Mount Sinai Medical Center, New York in 2003, followed by fellowships in Stroke/ Vascular Neurology and Neurological Critical Care at the UCLA Medical Center 2003-2005. In addition, he has several years of experience in private practice as an attending physician in medical/ surgical intensive care units. He joined the University of Michigan’s neurosurgery department 2008 as faculty neurointensivist and vascular neurologist. He has served as the medical director of neurocritical care since 2014 and as co-director of the comprehensive stroke center since 2017.Dr. Rajajee has had a clinical, educational, and research interest in critical care ultrasound since 2007. He is a diplomate of the National Board of Echocardiography. He has published several articles on optic nerve ultrasound and transcranial doppler in neurocritical care, and helped pioneer the use of real-time ultrasound guidance during bedside tracheostomy in 2011. Dr. Rajajee developed and directed the Neurocritical Care Society’s (NCS) annual critical care ultrasound workshop between 2012-2014, and has served on the Society of Critical Care Medicine’s (SCCM) Ultrasound Committee. He currently coordinates the University of Michigan’s multidisciplinary critical care ultrasound lecture series.His other interests include the monitoring and management of patients with severe Traumatic Brain Injury (TBI). In 2013, Michigan Medicine signed a memorandum of understanding on collaboration in research and education with the All India Institute of Medical Sciences (AIIMS), New Delhi, with TBI as a major focus. As part of this collaboration, Dr. Rajajee has received funding from the National Institutes of Health (NIH) to study techniques of intracranial pressure assessment applicable to low and middle income nations. He has also received funding from the Department of Defense (DoD) to evaluate noninvasive techniques to assess the brain following TBI.He is a former chair of the Neurocritical Care Society’s Guidelines Committee, and the GRADE methodologist of the NCS guidelines for neuroprognostication in neurocritical care. He is the first author of the 2023 Guidelines for Neuroprognostication in Comatose Adult Survivors of Cardiac Arrest. Dr. Rajajee is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, Gastrostomy, and Transmyocardial Revascularization.

Todd Hollon is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Hollon is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Prolactinoma, Brain Tumor, Awake Craniotomy, and Septoplasty.

Donna Edwards is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Edwards is rated as an Experienced provider by MediFind in the treatment of Schwannoma. Her clinical expertise encompasses Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Atypical Teratoid Rhabdoid Tumor (ATRT).

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Schwannoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.